|
WO2016063251A1
|
|
Reagents and methods for reactivation of latent hiv
|
|
DE102014213409A1
|
|
Method and device for displaying pathological changes in an examination object based on 3D data sets
|
|
WO2014140938A2
|
|
Immunological methods
|
|
EP2925310A1
|
|
Medicament comprising at least one omega-3 polyunsaturated fatty acid
|
|
EP2895269A1
|
|
Conical multi-well filter plate
|
|
WO2013030786A1
|
|
Method for diagnosing or predicting hepatocellular carcinoma outcome
|
|
CA2860056A1
|
|
Methods for differentiating between disease states of mycobacterium tuberculosis infection
|
|
WO2012073188A1
|
|
Chemoembolization composition comprising anti-angiogenic agents
|
|
WO2012059888A1
|
|
Method for detecting the presence of a dna minor contributor in a dna mixture
|
|
TW201219573A
|
|
Anti-fibrotic response provided by fetal cells to implants and delivery systems
|
|
EP2554139A1
|
|
Actuating device for a surgical implant
|
|
MX2012001058A
|
|
Methods for diagnosing or predicting hepatitis c outcome in hcv infected patients.
|
|
EP2414541A1
|
|
Methylation ligation-dependent macroarray (mlm)
|
